Baby Formula NEC Lawsuit Payout & Settlements

As mentioned, a global settlement has not been reached in the NEC baby formula lawsuits.

Our NEC baby formula lawyers are following the litigation closely, but there is no established average settlement amount or standardized payout for these claims.

The potential value of an NEC lawsuit varies based on the facts of the individual case, including the severity of the child’s injuries, medical treatment, permanent complications, future care needs, available evidence, and applicable state law.

Because each NEC claim involves different medical and legal circumstances, prior verdicts and settlements should not be viewed as predictions of what another family may recover.

Understanding Potential NEC Lawsuit Settlement Amounts

NEC lawsuit settlement amounts can vary substantially from one case to another, and there is no fixed formula for determining how much compensation may be available.

The value of an individual claim may depend on the severity of the child’s injuries, the medical treatment required, permanent complications, future care needs, and the strength of the evidence connecting a formula product to the NEC diagnosis.

Medical records from hospitals and other medical providers can help document the formula administered, the child’s condition, surgeries, intestinal damage, and long-term prognosis.

Compensation may account for medical expenses, pain and suffering, permanent impairment, future treatment and caregiving needs, wrongful death, and other damages available under applicable state law.

A child who recovers without significant permanent complications may have different damages from a child who required intestinal surgery, suffered extensive bowel loss, developed short bowel syndrome, sustained neurological or developmental injuries, or requires lifelong medical care.

Wrongful death claims also involve different categories of damages and may be evaluated under state-specific wrongful death and survival statutes.

The outcomes of state trials and federal bellwether proceedings may provide information about how courts and juries evaluate particular evidence, but they do not create a settlement schedule or establish what another NEC lawsuit is worth.

Each claim must instead be evaluated individually based on the child’s injuries, losses, supporting evidence, and the law governing the case.

When Will the NEC Lawsuit Be Settled?

No date has been announced for a global NEC baby formula settlement.

Federal cases remain consolidated in MDL No. 3026 in the Northern District of Illinois, while separate lawsuits are proceeding through Illinois state court and other state courts on individual timelines.

The litigation has produced mixed results.

A Missouri appeals court affirmed TorHoerman Law’s $495 million verdict against Abbott in May 2026, and an Illinois jury awarded $70 million to four families in April 2026.

A separate $60 million verdict against Mead Johnson was reversed by the Illinois Appellate Court in June 2026 and returned to the trial court for a new trial.

The first three cases selected for federal bellwether trials ended in summary judgment for Abbott before reaching juries.

The Inman case against Mead Johnson survived summary judgment and remains positioned to become the first federal bellwether trial in the MDL to reach a jury.

These outcomes may affect how Abbott, Mead Johnson, and plaintiffs evaluate individual claims, but they do not establish when or whether a broad settlement will occur.

Each NEC lawsuit may resolve through settlement, dismissal, trial, appeal, or another court ruling based on its own evidence and applicable law.

How May Settlement Amounts in the NEC Baby Formula Lawsuits Be Determined?

The potential value of an NEC lawsuit is evaluated by reviewing the child’s injuries, medical treatment, permanent complications, future needs, and the evidence supporting the claim against the formula manufacturer.

Compensation may include medical expenses, pain and suffering, future care costs, permanent impairment, and other damages permitted under applicable state law.

Factors that may affect an NEC lawsuit settlement include:

• Severity of the child’s injuries: Cases involving sepsis, intestinal perforation, surgery, extensive bowel removal, short bowel syndrome, developmental impairment, or permanent disability may involve different damages than cases in which the child recovers without lasting complications.
• Medical expenses incurred: Families may seek compensation for medical expenses associated with NEC, including NICU treatment, surgery, medications, specialized nutrition, rehabilitation, and follow-up care.
• Future medical and caregiving needs: Claims involving lifelong treatment, repeated surgeries, feeding support, therapy, medical equipment, or professional caregiving may require expert analysis of anticipated future costs.
• Pain, suffering, and quality of life: Compensation may account for the child’s physical pain, permanent impairment, emotional suffering, and reduced ability to participate in ordinary childhood activities.
• Formula exposure and medical evidence: Feeding logs, hospital records, product information, and testimony from medical providers can help establish which products were administered and when the child developed NEC. Medical and feeding records for formula-fed infants are often central to evaluating causation and damages.
• Strength of the liability evidence: Internal records, product warnings, scientific evidence, and expert testimony may affect the strength of allegations that Abbott, Mead Johnson, or another manufacturer failed to adequately warn about NEC risks.
• Wrongful death or survival damages: When an infant dies from NEC complications, the child’s estate and qualifying family members may pursue damages permitted under the wrongful death and survival laws of the applicable state.
• Governing state law and jurisdiction: State law may affect available damages, punitive damages standards, damage caps, filing deadlines, and the losses parents may recover in their own right.
• Prior verdicts and case outcomes: Prior NEC verdicts and court rulings may influence how the parties assess litigation risk and settlement positions, but they do not establish a fixed value or expected payout for another claim.

No single factor determines the value of an NEC lawsuit.

Our attorneys evaluate the medical evidence, damages, liability issues, applicable law, and long-term consequences of NEC when assessing an individual claim.

NEC baby formula lawsuits have been filed against Abbott Laboratories and Mead Johnson, the baby formula makers responsible for Similac and Enfamil products.

Plaintiffs allege that certain cow’s milk-based preterm formulas and fortifiers increased the risk of necrotizing enterocolitis among premature and low-birth-weight infants.

Each NEC formula lawsuit claims that the formula makers failed to adequately warn parents, hospitals, neonatologists, and other medical providers about reported differences in NEC rates between infants fed cow’s milk-based products and those receiving maternal or donor human milk.

NEC lawsuits also claim the manufacturers prioritized profits over infant safety by continuing to market the products without adequate NEC warnings.

Federal cases are coordinated in MDL No. 3026 in the Northern District of Illinois for shared pretrial proceedings.

Families maintain individual lawsuits, and compensation is evaluated according to the child’s formula exposure, medical history, injuries, treatment, permanent complications, and applicable state law.

Separate NEC lawsuits are also proceeding in state courts.

TorHoerman Law obtained a $495 million verdict against Abbott in Missouri, and an Illinois jury awarded $70 million to four families in April 2026.

A separate $60 million verdict against Mead Johnson was reversed on appeal and returned to the trial court for a new trial.

These results demonstrate that NEC cases can produce substantial jury awards, but they do not establish an average settlement amount or guarantee compensation in another claim.

Federal and state cases have produced different outcomes based on the evidence, expert testimony, governing law, and circumstances of each child’s diagnosis.

If your child developed NEC after receiving Similac, Enfamil, or another cow’s milk-based preterm formula or fortifier, you may qualify to file an NEC baby formula lawsuit.

Contact TorHoerman Law for a free consultation and case review.

Which Manufacturers Are Named in NEC Baby Formula Lawsuits?

NEC baby formula lawsuits primarily name the companies responsible for the Similac and Enfamil baby formula brands.

The claims generally involve specific cow’s milk-based preterm formulas and fortifiers rather than every product sold under either brand.

The primary companies named in NEC lawsuits include:

• Abbott Laboratories: Abbott manufactures Similac formula products, including specialized preterm formulas and human milk fortifiers administered to premature and low-birth-weight infants.
• Mead Johnson & Company: Mead Johnson manufactures Enfamil formula products, including Enfamil baby formula and human milk fortifiers used in hospitals and neonatal intensive care units.

Plaintiffs allege that Abbott and Mead Johnson failed to adequately warn parents, hospitals, neonatologists, and other medical providers about reported NEC risks associated with certain products.

An Enfamil baby formula case or Similac lawsuit may depend on medical and feeding records identifying the exact product administered, the timing of exposure, and the child’s subsequent NEC diagnosis.

Families should not assume that all Similac and Enfamil products are included in the litigation.

Attorneys must review the child’s records to determine whether the formula or fortifier used supports a claim against one or both manufacturers.

Overview of the NEC Baby Formula MDL

The NEC infant formula MDL, formally known as MDL No. 3026, centralizes federal lawsuits against both Abbott Laboratories and Mead Johnson in the U.S. District Court for the Northern District of Illinois.

Judge Rebecca R. Pallmeyer oversees coordinated discovery, expert proceedings, pretrial motions, and bellwether test trials.

The MDL does not combine every family into a single lawsuit or class action.

Each plaintiff retains an individual claim based on the child’s formula exposure, NEC diagnosis, injuries, and damages.

Many lawsuits are handled in individual state courts or federal multidistrict litigation.

State-court cases proceed separately, while federal cases that do not settle or otherwise resolve may eventually proceed to trial under the applicable procedural rules.

Necrotizing enterocolitis (NEC) is a life-threatening intestinal disease that primarily affects premature and low-birth-weight infants.

The condition causes inflammation and damage to the intestinal wall, which can progress to tissue death, intestinal perforation, sepsis, and organ failure.

The exact cause of NEC is not fully understood.

Medical researchers believe it develops through several interacting factors, including prematurity, intestinal immaturity, altered bacterial colonization, inflammation, and feeding-related factors.

Common signs of NEC include abdominal swelling, feeding intolerance, bloody stools, vomiting, and lethargy.

Treatment may require stopping enteral feeding, bowel rest, intravenous nutrition, antibiotics, close monitoring, and surgery to remove damaged sections of the intestine in severe cases.

Infants who survive NEC may experience short bowel syndrome, feeding difficulties, developmental impairments, chronic intestinal problems, or other complications requiring long-term medical care.

NEC baby formula lawsuits allege that certain cow’s milk-based preterm formulas and fortifiers increased the risk of NEC and were sold without adequate warnings to parents and medical providers.

A family may qualify to file an NEC lawsuit when medical records show that a premature infant received a qualifying Similac baby formula or Enfamil preterm product before developing the condition.

Contact TorHoerman Law for a free consultation and review of your child’s medical and feeding records.

Cow’s Milk-Based Formula and the Risk of NEC

Research has consistently reported lower rates of necrotizing enterocolitis among premature infants receiving breast milk than among infants fed only cow’s milk-based formula.

In a prospective multicenter study of 926 preterm infants, confirmed NEC occurred six to 10 times more often among exclusively formula-fed infants than among infants receiving breast milk alone.

Prematurity and low birth weight remain the primary underlying risk factors for NEC.

Approximately 5% of very premature or very-low-birth-weight infants develop NEC, while the rate approaches 10% among extremely premature or extremely low birth weight babies.

In one study limited to extremely low-birth-weight infants, NEC occurred in 11.1% of those fed only preterm formula, compared with 1.3% of infants whose diet consisted almost entirely of their mother’s milk.

Human breast milk contains immune and growth factors that help support intestinal development and protect the immature digestive system.

When a mother’s own milk is unavailable, donor human milk has also been associated with a lower NEC rate than formula among extremely premature infants, although specialized preterm formula may still be medically necessary when an adequate human milk supply is unavailable.

NEC can cause intestinal tissue death, perforation, sepsis, short bowel syndrome, neurological injury, and other permanent complications.

Overall mortality is commonly estimated at 20% to 30%, while mortality may approach 50% among infants who require surgery or develop severe NEC.

Research examining feeding practices and NEC includes:

• Lucas and Cole multicenter study: Researchers found that confirmed NEC was six to 10 times more common among exclusively formula-fed premature infants than among infants fed breast milk alone.
• Extremely low-birth-weight infant study: NEC occurred in 11.1% of infants fed only preterm formula, compared with 1.3% of infants receiving a diet composed almost entirely of maternal milk.
• NIH-funded donor milk trial: Extremely premature infants assigned to donor human milk experienced approximately half the NEC rate of infants assigned to preterm formula.

The Impact of NEC on Families

An NEC diagnosis can place parents under immediate emotional strain as they face emergency treatment, uncertain survival, and the possibility of permanent injury.

Families may experience anxiety, post-traumatic stress, sleep disruption, and persistent fear about their child’s long-term health.

The financial effects can include prolonged NICU care, surgery, repeated hospitalizations, specialized nutrition, therapy, medical equipment, travel expenses, and continuing treatment with pediatric specialists.

Parents may also miss work, reduce their hours, or leave employment to care for a child with serious complications.

Children who develop short bowel syndrome, feeding difficulties, neurological impairment, developmental delays, or dependence on enteral or intravenous nutrition may require years of medical care and daily support.

These needs can affect housing, employment, childcare, education, and nearly every part of family life.

An NEC lawsuit may seek compensation for the child’s medical expenses, pain and suffering, permanent impairment, and future care needs.

Parental lost income, emotional distress, and other family losses may also be considered when permitted under applicable state law.

TorHoerman Law served as lead trial counsel in Gill v. Abbott Laboratories, a Missouri state-court case that resulted in a $495 million jury verdict on July 26, 2024.

The case involved Margo Gill and her daughter Robynn, who developed necrotizing enterocolitis after receiving Similac preterm infant formula in the NICU.

At trial, the plaintiffs argued that Abbott knew premature infants fed cow’s milk-based formula faced higher reported NEC rates than infants receiving human milk but failed to provide adequate warnings to parents and medical providers.

The evidence included Robynn’s feeding and medical records, scientific testimony, internal company documents, and information presented to the jury about Abbott’s knowledge of the relationship between formula feeding and NEC.

Robynn required the removal of approximately 75% of her intestines and suffered permanent brain damage following her NEC diagnosis.

The trial evidence showed that she would require extensive medical treatment, specialized care, and support throughout her life.

The jury awarded $95 million in compensatory damages for Robynn’s injuries, medical needs, permanent impairment, and other losses. It also awarded $400 million in punitive damages, bringing the total verdict to $495 million.

The Missouri Court of Appeals affirmed the judgment in May 2026.

The verdict remains one of the most significant results in the NEC baby formula litigation and reflects the substantial damages that may arise when a child suffers catastrophic and permanent complications.

The Gill verdict was an individual jury result based on the evidence presented in that case.

It does not establish an average NEC settlement amount or guarantee that another lawsuit will produce the same outcome.

Parents, legal guardians, or estate representatives may qualify to file an NEC baby formula lawsuit when medical records show that a premature infant received a qualifying cow’s milk-based preterm formula or fortifier before developing necrotizing enterocolitis.

Many claims involve premature babies who were fed formula products sold under the Similac or Enfamil brands while receiving treatment in a hospital or NICU.

Potential NEC claims may include:

• Product liability claims: Families may pursue claims against Abbott Laboratories or Mead Johnson based on allegations that the manufacturers failed to adequately warn parents and medical providers about the NEC risks associated with certain preterm formulas and fortifiers.
• Wrongful death and survival claims: When an infant dies from NEC complications, the child’s estate and qualifying family members may be able to file a wrongful death lawsuit and related survival claims under applicable state law.

Eligibility depends on the child’s gestational age, birth weight, formula exposure, NEC diagnosis, injuries, medical records, and the filing deadline that applies to the claim.

A diagnosis after formula exposure does not automatically establish liability, and each case requires an individual review of the medical and legal evidence.

TorHoerman Law’s NEC cases focus on claims against infant formula manufacturers rather than medical providers.

If your child developed NEC after being fed formula in a hospital or NICU, contact our attorneys for a free consultation and review of the child’s feeding and treatment records.

Gathering Evidence for Toxic Baby Formula NEC Lawsuits

Evidence in an NEC baby formula lawsuit helps document the child’s formula exposure, the timing of the NEC diagnosis, the resulting injuries, and the damages claimed against the manufacturer.

Medical and feeding records are especially important because NEC in premature infants can involve several underlying risk factors that must be evaluated alongside the products administered.

Relevant evidence may include:

• Birth and NICU records: Records showing the child’s gestational age, birth weight, medical condition, and treatment following delivery.
• Daily feeding logs: Documentation identifying whether the infant received Similac, Enfamil, a human milk fortifier, mother’s milk, donor milk, or another nutritional product.
• Formula and fortifier records: Product names, caloric formulations, administration dates, lot information, and records showing whether the child was initially fed human milk before receiving a cow’s milk-based product.
• NEC diagnostic records: Medical notes, imaging, laboratory results, and documentation of the child’s NEC diagnosis, stage, symptoms, and clinical progression.
• Surgical and pathology records: Operative reports showing intestinal perforation, bowel resection, ostomy placement, the amount of intestine removed, and other severe complications.
• Long-term treatment records: Documentation of short bowel syndrome, feeding difficulties, neurological injury, developmental delays, specialized nutrition, rehabilitation, or continuing medical care.
• Damages documentation: Medical bills, insurance statements, caregiving expenses, employment records, photographs, and records describing how NEC affected the child’s health and daily life.
• Wrongful death records: A death certificate, autopsy report, final hospitalization records, and estate documents when an infant dies from NEC complications.

Families may provide records already in their possession, while attorneys can request additional hospital documents and work with medical experts to review the child’s feeding history and injuries.

Lawyers may also obtain product warnings, internal manufacturer records, corporate testimony, and other evidence through the discovery process.

Damages in Baby Formula NEC Lawsuits

Damages in an NEC baby formula lawsuit refer to the monetary relief sought for losses attributed to the child’s injuries and the alleged conduct of the formula manufacturer.

Attorneys evaluate medical records, expert opinions, future care projections, and applicable state law to determine which damages may be pursued.

Potential damages may include:

• Past medical expenses: Costs associated with NICU care, surgery, hospitalization, medication, imaging, specialist treatment, and other care related to NEC.
• Future medical care: Projected expenses for repeated surgeries, specialized nutrition, rehabilitation, developmental therapy, medical equipment, and continuing treatment.
• Professional caregiving and support: The cost of in-home care, nursing assistance, feeding support, and other services required by a child with permanent complications.
• Pain and suffering: Compensation for the child’s physical pain, emotional distress, invasive treatment, permanent impairment, and reduced quality of life.
• Permanent injuries: Damages associated with short bowel syndrome, extensive intestinal loss, neurological injury, developmental impairment, feeding difficulties, or other lasting conditions.
• Parental financial losses: Lost income, caregiving expenses, and related losses may be recoverable when permitted under applicable state law.
• Wrongful death and survival damages: When an infant dies from NEC complications, qualifying family members and the child’s estate may pursue damages available under state wrongful-death and survival laws.

Punitive damages may also be available when the evidence and governing law support a finding of particularly wrongful, reckless, or willful conduct.

These damages are intended to punish and deter misconduct rather than compensate the family for a specific financial loss.

The damages available in an individual NEC lawsuit depend on the child’s injuries, future needs, whether the child survived, the evidence supporting the claim, and the law of the state governing the case.

TorHoerman Law is a nationally recognized product liability firm that obtained a $495 million verdict against Abbott Laboratories in an NEC premature infant formula trial.

Our attorneys review medical records, NICU feeding histories, formula exposure, permanent injuries, future care needs, and other evidence to assess potential claims against infant formula manufacturers.

Parents, legal guardians, and estate representatives may qualify to file an NEC baby formula lawsuit when a premature infant developed necrotizing enterocolitis after receiving a qualifying cow’s milk-based preterm formula or fortifier.

Every claim requires an individual review of the child’s medical history, injuries, applicable filing deadline, and governing state law.

If your child developed NEC after receiving Similac, Enfamil, or another cow’s milk-based preterm product in a hospital or NICU, contact TorHoerman Law for a free, no-obligation consultation.

You can also use the chat feature on this page to begin a free case evaluation.